Influenza
New findings from Germany, the United States and Japan in the area of influenza detailed
Published in TB and Outbreaks Week, June 6th, 2006
Study 1: An influenza epidemic strain is converted into a genetically homologous attenuated virus.
"A promising approach to reduce the impact of influenza is the use of an attenuated life virus as a vaccine. Using reverse genetics, a mutant of strain A/WSN/33 with a modified cleavage site within its hemagglutinin was generated which depends on proteolytic activation by elastase," investigators in Germany report.
According to the authors, "Unlike the wild-type requiring trypsin, this mutant is strictly dependent on elastase. Both viruses grow...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Gastroenteritis Outbreaks
Gastroenteritis gradient assesses long-term sequelae risk after drinking contaminated water - Toxoplasmosis Epidemiology
Toxoplasmosis is highly prevalent in newborns in Armenia - Tuberculosis Screening
Tuberculosis screening models widely disparate among European countries - Water Contamination
Multiple drug-resistant heterotrophic bacteria load is high in bottled water in India - Antituberculosis Drug Development
Diclofenac acid hydrazones and amides active against Mycobacterium tuberculosis - Avian Influenza
Infants or adults? U.S. NIH ethicists argue for new avian influenza priorities - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
